Updated Mar. 29, 2014 at 1:07 p.m.

Premium Lock Scynexis lands Russian partner for anti-fungal drug headed for phase II trials

Published: 2013-09-10 19:13:00
Updated: 2014-03-29 13:07:13

Scynexis Scynexis

The deal expands the market potential for an anti-fungal compound Scynexis originally partnered with Merck. Read about why this drug could have an advantage other anti-fungals in its class....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders